Everest Re Group Ltd. (RE)
NYSE: RE
· Real-Time Price · USD
351.28
10.00 (2.93%)
At close: Jul 07, 2023, 10:00 PM
Everest Re Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Insurance Revenue | 3.58B |
| Insurance Revenue Growth | n/a |
| Other Operating Segment Revenue | 197M |
| Other Operating Segment Revenue Growth | n/a |
| Reinsurance Revenue | 11.41B |
| Reinsurance Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|
| Domestic Country Revenue | 4.17B | 3.64B | 3.36B | 3.22B | 3.02B | 2.71B | 2.27B | 2.13B |
| Domestic Country Revenue Growth | +14.41% | +8.30% | +4.47% | +6.70% | +11.37% | +19.40% | +6.33% | n/a |
| International Country Revenue | 1.44B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| International Country Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | n/a | n/a | n/a | 22M | 22M | 18M | 19M | 17M | 19M | 16M | 16M | 15.02M | 14.02M | 21.46M | 17.82M | 16.17M | 12.38M | 11.93M | 10.62M | 8.73M | 9.83M | 10.34M | 8.44M | 7.54M | 6.65M | 7.15M | 7.89M | 6.63M | 9M | 4.62M | 5.93M | 6.92M | 8.46M | 5.83M | 6.4M | 7.12M | 7.89M | 5.94M | 5.92M | 5.92M | 5.46M |
| Selling, General, and Administrative Revenue Growth | n/a | n/a | n/a | -100.00% | 0.00% | +22.22% | -5.26% | +11.76% | -10.53% | +18.75% | 0.00% | +6.54% | +7.12% | -34.68% | +20.47% | +10.20% | +30.62% | +3.72% | +12.39% | +21.58% | -11.19% | -4.94% | +22.63% | +11.94% | +13.27% | -7.00% | -9.34% | +18.95% | -26.27% | +94.93% | -22.20% | -14.27% | -18.19% | +45.11% | -8.94% | -10.07% | -9.75% | +32.72% | +0.30% | -0.02% | +8.46% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |